112 related articles for article (PubMed ID: 6927305)
21. View from the Nation's Capitol.
Romansky MA
J Clin Psychopharmacol; 1982 Aug; 2(4):289-90. PubMed ID: 6926926
[No Abstract] [Full Text] [Related]
22. Drug test warning.
Whitmore TC
Nature; 2001 Jun; 411(6838):633. PubMed ID: 11395739
[No Abstract] [Full Text] [Related]
23. Extra-label drug use--pharmaceutical industry view.
Welser JR
J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
[No Abstract] [Full Text] [Related]
24. Enterprise liability for bad outcomes from drug therapy: the doctor, the hospital, the pharmacy, and the drug firm.
Furrow BR
Spec Law Dig Health Care Law; 1998 Apr; (229):9-69. PubMed ID: 10178162
[No Abstract] [Full Text] [Related]
25. [Orphan drugs].
Kolár J; Chalabala M; Srámková H
Ceska Slov Farm; 2001 Mar; 50(2):59-65. PubMed ID: 11288591
[TBL] [Abstract][Full Text] [Related]
26. Prescription for the Orphan Drug Act: the impact of the FDA's 1992 regulations and the latest congressional proposals for reform.
Clissold DB
Food Drug Law J; 1995; 50(1):125-47. PubMed ID: 10342989
[No Abstract] [Full Text] [Related]
27. FDA's interferon-beta decision reignites orphan debate.
Marshall A
Nat Biotechnol; 1999 Apr; 17(4):324-5. PubMed ID: 10207871
[No Abstract] [Full Text] [Related]
28. View from the Nation's Capital.
Appler WD
J Clin Psychopharmacol; 1985 Dec; 5(6):350-2. PubMed ID: 4067003
[No Abstract] [Full Text] [Related]
29. Rare diseases, orphan drugs, and orphaned patients.
Scheindlin S
Mol Interv; 2006 Aug; 6(4):186-91. PubMed ID: 16960139
[No Abstract] [Full Text] [Related]
30. Orphan products--pain relief for clinical development headaches.
Milne CP
Nat Biotechnol; 2002 Aug; 20(8):780-4. PubMed ID: 12148001
[No Abstract] [Full Text] [Related]
31. [Distribution of orphan drugs by the pharmacist of the Faculty of Veterinary Medicine].
Tijdschr Diergeneeskd; 2004 Jul 15-Aug 1; 129(14-15):486. PubMed ID: 15344826
[No Abstract] [Full Text] [Related]
32. 1989 annual survey--133 orphan drug products.
Hosp Pharm; 1990 Apr; 25(4):367-71, 375-86. PubMed ID: 10104391
[No Abstract] [Full Text] [Related]
33. Drugs bill to rein in profits.
Gershon D
Nature; 1994 Mar; 368(6470):381. PubMed ID: 8133874
[No Abstract] [Full Text] [Related]
34. Patients mutiny against Orphan Drug Act.
Margolid RE
Healthspan; 1992 Feb; 9(2):25-6. PubMed ID: 10117860
[No Abstract] [Full Text] [Related]
35. [Orphan drugs: what are they and why do they not find adoptive parents?].
Lechat P
Therapie; 1987; 42(1):33-6. PubMed ID: 3590064
[No Abstract] [Full Text] [Related]
36. The Minor Use and Minor Species Animal Health Act: past, present, and future.
Haley CJ
Food Drug Law J; 2006; 61(1):13-43. PubMed ID: 16838456
[No Abstract] [Full Text] [Related]
37. [Pharmacotherapy between theory and practice].
Stricker BH
Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2295-6. PubMed ID: 7501059
[No Abstract] [Full Text] [Related]
38. Adoption agent.
Peota C
Minn Med; 2005 Mar; 88(3):8-9. PubMed ID: 15852583
[No Abstract] [Full Text] [Related]
39. Experimental use and the Orphan Drug Act: a biotechnology conundrum.
Koivuniemi PJ
Nat Biotechnol; 1996 Apr; 14(4):511-2. PubMed ID: 9630930
[No Abstract] [Full Text] [Related]
40. Pharmaceuticals. Adopt an orphan.
Karr A
Health Serv J; 1999 Nov; 109(5681):28. PubMed ID: 10724720
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
